200
Views
67
CrossRef citations to date
0
Altmetric
Review

Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance

, , &
Pages 475-484 | Published online: 10 Jan 2014

References

  • Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA282(7), 677–686 (1999).
  • Kochi A. Tuberculosis: distribution, risk factors, mortality. Immunobiology191(4–5), 325–336 (1994).
  • Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle72(1), 1–6 (1991).
  • Gonzalez-Juarrero M, Turner OC, Turner J, Marietta P, Brooks JV, Orme IM. Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect. Immun.69(3), 1722–1728 (2001).
  • Kaufmann SH. Protection against tuberculosis: cytokines, T cells, and macrophages. Ann. Rheum. Dis.61(Suppl. 2:ii), 54–58 (2002).
  • Kaufmann SH. Recent findings in immunology give tuberculosis vaccines a new boost. Trends Immunol.26(12), 660–667 (2005).
  • Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med.178(6), 2249–2254 (1993).
  • Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med.335(26), 1941–1949 (1996).
  • Jouanguy E, Doffinger R, Dupuis S, Pallier A, Altare F, Casanova JL. IL-12 and IFN-γ in host defense against mycobacteria and salmonella in mice and men. Curr. Opin. Immunol.11(3), 346–351 (1999).
  • Jouanguy E, Lamhamedi-Cherradi S, Lammas D et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet.21(4), 370–378 (1999).
  • Altare F, Lammas D, Revy P et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J. Clin. Invest.102(12), 2035–2040 (1998).
  • Lamhamedi S, Jouanguy E, Altare F, Roesler J, Casanova JL. Interferon-γ receptor deficiency: relationship between genotype, environment, and phenotype (review). Int. J. Mol. Med.1(2), 415–418 (1998).
  • Stenger S, Modlin RL. T cell mediated immunity to Mycobacterium tuberculosis. Curr. Opin. Microbiol.2(1), 89–93 (1999).
  • Shams H, Wizel B, Weis SE, Samten B, Barnes PF. Contribution of CD8(+) T cells to γ interferon production in human tuberculosis. Infect. Immun.69(5), 3497–3501 (2001).
  • Serbina NV, Flynn JL. CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis. Infect. Immun.69(7), 4320–4328 (2001).
  • Hoft DF, Brown RM, Roodman ST. Bacille Calmette–Guerin vaccination enhances human γ δ T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J. Immunol.161(2), 1045–1054 (1998).
  • Dieli F, Caccamo N, Meraviglia S et al. Reciprocal stimulation of γδ T cells and dendritic cells during the anti-mycobacterial immune response. Eur. J. Immunol.34(11), 3227–3235 (2004).
  • Elias D, Akuffo H, Britton S. PPD induced in vitro interferon γ production is not a reliable correlate of protection against Mycobacterium tuberculosis. Trans. R. Soc. Trop. Med. Hyg.99(5), 363–368 (2005).
  • Rook GA, Dheda K, Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat. Rev. Immunol.5, 661–667 (2005).
  • Hori S, Takahashi T, Sakaguchi S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv. Immunol.81, 331–371 (2003).
  • Wood KJ, Ushigome H, Karim M, Bushell A, Hori S, Sakaguchi S. Regulatory cells in transplantation. Novartis Found Symp.252, 177–188 (2003).
  • Hori S, Sakaguchi S. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect.6(8), 745–751 (2004).
  • Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat. Immunol.6(4), 353–360 (2005).
  • Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet367(9517), 1173–1180 (2006).
  • Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet346(8986), 1339–1345 (1995).
  • Ponnighaus JM, Fine PE, Sterne JA et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet339(8794), 636–639 (1992).
  • WHO. WHO declares tuberculosis a global emergency. Sozial Praventivmedizin38(4), 251–252 (1993).
  • Skeiky YA, Alderson MR, Ovendale PJ et al. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J. Immunol.172(12), 7618–7628 (2004).
  • Olsen AW, Williams A, Okkels LM, Hatch G, Andersen P. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect. Immun.72(10), 6148–6150 (2004).
  • McShane H, Pathan AA, Sander CR et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med.10(11), 1240–1244 (2004).
  • Chan MS. The global burden of intestinal nematode infections – fifty years on. Parasitol.Today13(11), 438–443 (1997).
  • Bethony J, Brooker S, Albonico M et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet367(9521), 1521–1532 (2006).
  • King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet365(9470), 1561–1569 (2005).
  • Cancrini G. Human infections due to nematode helminths nowadays: epidemiology and diagnostic tools. Parasitologia48(1–2), 53–56 (2006).
  • Cappello M. Global health impact of soil-transmitted nematodes. Pediatr. Infect. Dis. J.23(7), 663–664 (2004).
  • Khuroo MS. Ascariasis. Gastroenterol. Clin. North Am.25(3), 553–577 (1996).
  • Kar Pui Lau S, Woo PC, Wong SS, Ma ES, Yuen KY. Ascaris-induced eosinophilic pneumonitis in an HIV-infected patient. J. Clin. Pathol.60(2), 202–203 (2007).
  • Casati A, Cornero G, Muttini S, Tresoldi M, Gallioli G, Torri G. Hyperacute pneumonitis in a patient with overwhelming Strongyloides stercoralis infection. Eur. J. Anaesthesiol.13(5), 498–501 (1996).
  • Stephenson LS, Latham MC, Ottesen EA. Malnutrition and parasitic helminth infections. Parasitology121(Suppl.), S23–S38 (2000).
  • Chu D, Bungiro RD, Ibanez M et al. Molecular characterization of Ancylostoma ceylanicum Kunitz-type serine protease inhibitor: evidence for a role in hookworm-associated growth delay. Infect. Immun.72(4), 2214–2221 (2004).
  • Wilson MS, Maizels RM. Regulation of allergy and autoimmunity in helminth infection. Clin. Rev. Allergy Immunol.26(1), 35–50 (2004).
  • Bundy D, Sher A, Michael E. Good worms or bad worms: do worm infections affect the epidemiological patterns of other diseases? Parasitol. Today16(7), 273–274 (2000).
  • Stromberg BE. Potentiation of reagenic (IgE) antobody response to ovalbumin in the guinea pig with a soluble metabolic product from Ascaris suum. J. Immunol.125, 833–836 (1980).
  • Bradley JE, Jackson JA. Immunity, immunoregulation and the ecology of trichuriasis and ascariasis. Parasite Immunol.26(11–12), 429–441 (2004).
  • Elias D, Akuffo H, Pawlowski A, Haile M, Schon T, Britton S. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine23(11), 1326–1334 (2005).
  • Romagnani S. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int. J. Clin. Lab. Res.21(2), 152–158 (1991).
  • Boitelle A, Scales HE, Di Lorenzo C et al. Investigating the impact of helminth products on immune responsiveness using a TCR transgenic adoptive transfer system. J. Immunol.171(1), 447–454 (2003).
  • Borkow G, Bentwich Z. Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin. Microbiol. Rev.17(4), 1012–1030 (2004).
  • Borkow G, Leng Q, Weisman Z et al. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J. Clin. Invest.106(8), 1053–1060 (2000).
  • Borkow G, Weisman Z, Leng Q et al. Helminths, human immunodeficiency virus and tuberculosis. Scand. J. Infect. Dis.33(8), 568–571 (2001).
  • Shevach EM. Certified professionals: CD4(+)CD25(+) suppressor T cells. J. Exp. Med.193(11), F41–F46 (2001).
  • Babu S, Blauvelt CP, Kumaraswami V, Nutman TB. Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence. J. Immunol.176(5), 3248–3256 (2006).
  • Doetze A, Satoguina J, Burchard G et al. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-β but not by a T(h)1 to T(h)2 shift. Int. Immunol.12(5), 623–630 (2000).
  • Fine PE. Bacille Calmette–Guerin vaccines: a rough guide. Clin. Infect. Dis.20(1), 11–14 (1995).
  • Curry AJ, Else KJ, Jones F, Bancroft A, Grencis RK, Dunne DW. Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris. J. Exp. Med.181(2), 769–774 (1995).
  • Helmby H, Kullberg M, Troye-Blomberg M. Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections. Infect. Immun.66(11), 5167–5174 (1998).
  • Hoerauf A, Satoguina J, Saeftel M, Specht S. Immunomodulation by filarial nematodes. Parasite Immunol.27(10–11), 417–429 (2005).
  • Schonemeyer A, Lucius R, Sonnenburg B et al. Modulation of human T cell responses and macrophage functions by onchocystatin, a secreted protein of the filarial nematode Onchocerca volvulus. J. Immunol.167(6), 3207–3215 (2001).
  • Stewart GR, Boussinesq M, Coulson T, Elson L, Nutman T, Bradley JE. Onchocerciasis modulates the immune response to mycobacterial antigens. Clin. Exp. Immunol.117(3), 517–523 (1999).
  • Stadecker MJ, Kamisato JK, Chikunguwo SM. Induction of T helper cell unresponsiveness to antigen by macrophages from schistosomal egg granulomas. A basis for immunomodulation in schistosomiasis? J. Immunol.145(8), 2697–2700 (1990).
  • Feldmeier H, Gastl GA, Poggensee U, Kortmann C, Daffalla AA, Peter HH. Relationship between intensity of infection and immunomodulation in human schistosomiasis. II. NK cell activity and in vitro lymphocyte proliferation. Clin. Exp. Immunol.60(2), 234–240 (1985).
  • Ayash-Rashkovsky M, Weisman Z, Diveley J, Moss RB, Bentwich Z, Borkow G. Generation of Th1 immune responses to inactivated, gp120-depleted HIV-1 in mice with a dominant Th2 biased immune profile via immunostimulatory oligonucleotides – relevance to AIDS vaccines in developing countries. Vaccine20(21–22), 2684–2692 (2002).
  • Ayash-Rashkovsky M, Weisman Z, Zlotnikov S, Raz E, Bentwich Z, Borkow G. Induction of antigen-specific Th1-biased immune responses by plasmid DNA in schistosoma-infected mice with a preexistent dominant Th2 immune profile. Biochem. Biophys. Res. Comm.282(5), 1169–1176 (2001).
  • Bentwich Z, Kalinkovich A, Weisman Z, Borkow G, Beyers N, Beyers AD. Can eradication of helminthic infections change the face of AIDS and tuberculosis? Immunol. Today20(11), 485–487 (1999).
  • Kalinkovich A, Weisman Z, Greenberg Z et al. Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin. Exp. Immunol.114(3), 414–421 (1998).
  • Bentwich Z, Weisman Z, Moroz C, Bar-Yehuda S, Kalinkovich A. Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections? Clin. Exp. Immunol.103(2), 239–243 (1996).
  • Elias D, Akuffo H, Thors C, Pawlowski A, Britton S. Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin. Exp. Immunol.139(3), 398–404 (2005).
  • Actor JK, Marshall MA, Eltoum IA, Buller RM, Berzofsky JA, Sher A. Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation. Eur. J. Immunol.24(12), 3050–3056 (1994).
  • Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, Berzofsky JA. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc. Natl Acad. Sci. USA90(3), 948–952 (1993).
  • Bogdan C, Vodovotz Y, Paik J, Xie QW, Nathan C. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leuk. Biol.55(2), 227–233 (1994).
  • Rook GA, Dheda K, Zumla A. Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? Vaccine23(17–18), 2115–2120 (2005).
  • Elias D, Mengistu G, Akuffo H, Britton S. Are intestinal helminths risk factors for developing active tuberculosis? Trop. Med. Int. Health11(4), 551–558 (2006).
  • Warren R, Hauman J, Beyers N et al. Unexpectedly high strain diversity of Mycobacterium tuberculosis in a high-incidence community. Suid-Afrikaanse Tydskrif Geneeskunde86(1), 45–49 (1996).
  • Tristao-Sa R, Ribeiro-Rodrigues R, Johnson LT, Pereira FE, Dietze R. Intestinal nematodes and pulmonary tuberculosis. Rev. Soc. Bras. Med. Trop. 35(5), 533–535 (2002).
  • Diniz LM, Zandonade E, Dietze R, Pereira FE, Ribeiro-Rodrigues R. Short report: do intestinal nematodes increase the risk for multibacillary leprosy? Am. J. Trop. Med. Hyg.65(6), 852–854 (2001).
  • Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin. Exp. Immunol.123(2), 219–225 (2001).
  • Shapira-Nahor O, Kalinkovich A, Weisman Z et al. Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS12(13), 1731–1733 (1998).
  • Gopinath R, Ostrowski M, Justement SJ, Fauci AS, Nutman TB. Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. J. Infect. Dis.182(6), 1804–1808 (2000).
  • Wolday D, Mayaan S, Mariam ZG et al. Treatment of intestinal worms is associated with decreased HIV plasma viral load. AIDS31(1), 56–62 (2002).
  • Gallagher M, Malhotra I, Mungai PL et al. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS19(16), 1849–1855 (2005).
  • Chenine AL, Buckley KA, Li PL et al. Schistosoma mansoni infection promotes SHIV clade C replication in rhesus macaques. AIDS19(16), 1793–1797 (2005).
  • Jaffar S, Grant AD, Whitworth J, Smith PG, Whittle H. The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull. World Health Organ.82(6), 462–469 (2004).
  • Mekonnen Y, Geskus RB, Hendriks JC et al. Low CD4 T cell counts before HIV-1 seroconversion do not affect disease progression in Ethiopian factory workers. J. Infect. Dis.192(5), 739–748 (2005).
  • Brown M, Mawa PA, Joseph S et al. Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults. J. Infect. Dis.191(10), 1648–1657 (2005).
  • Modjarrad K, Zulu I, Redden DT et al. Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. J. Infect. Dis.192(7), 1277–1283 (2005).
  • Sewell D, Qing Z, Reinke E et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int. Immunol.15(1), 59–69 (2003).
  • Sewell DL, Reinke EK, Hogan LH, Sandor M, Fabry Z. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol. Lett.82(1–2), 101–110 (2002).
  • Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med.347(12), 911–920 (2002).
  • Correale J, Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann. Neurol.61(2), 97–108 (2007).
  • Summers RW, Elliott DE, Qadir K, Urban JF Jr, Thompson R, Weinstock JV. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am. J. Gastroenterol.98(9), 2034–2041 (2003).
  • van den Biggelaar AH, van Ree R, Rodrigues LC et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet356(9243), 1723–1727 (2000).
  • Selassie FG, Stevens RH, Cullinan P et al. Total and specific IgE (house dust mite and intestinal helminths) in asthmatics and controls from Gondar, Ethiopia. Clin. Exp. Allergy30(3), 356–358 (2000).
  • Wilson MS, Taylor MD, Balic A, Finney CA, Lamb JR, Maizels RM. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J. Exp. Med.202(9), 1199–1212 (2005).
  • Cooper PJ, Chico ME, Vaca MG et al. Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster-randomised trial. Lancet 367(9522), 1598–1603 (2006).
  • Mortimer K, Brown A, Feary J et al. Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. Am. J. Trop. Med. Hyg.75(5), 914–920 (2006).
  • Strachan DP, Taylor EM, Carpenter RG. Family structure, neonatal infection, and hay fever in adolescence. Arch. Dis. Child.74(5), 422–426 (1996).
  • Weinstock JV, Summers RW, Elliott DE, Qadir K, Urban JF Jr, Thompson R. The possible link between de-worming and the emergence of immunological disease. J. Lab. Clin. Med.139(6), 334–338 (2002).
  • Moreels TG, Nieuwendijk RJ, De Man JG et al. Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut53(1), 99–107 (2004).
  • Brunet LR, Hunt J, Rook GA. Dangers of therapeutic manipulation of the Th–Th2 balance. Trends Immunol.23(3), 127–128 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.